Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Singapore downtown district © GettyImages/Matteo Colombo

GSK, Sanofi, and Takeda align with research communities to advance Singapore's biologics manufacturing capabilities

Global pharma giants, GSK, Sanofi, and Takeda, are set to collaborate with Singapore researchers to boost innovation in local biologics and vaccines manufacturing.

Licensing deal aimed at progressing cell and gene therapies in the treatment of rare diseases

Curamys, a South Korean biotech developing cell and gene therapy using cell fusion technology to treat rare intractable diseases, has signed a strategic platform licensing agreement with US tech developer, MaxCyte.

Intravacc launches phase 1 trial for intranasal COVID-19 booster vaccine

Intravacc has enrolled the first participant in a phase I first in-human clinical trial of Avacc 10, the company’s SARS-CoV-2 intranasal subunit vaccine, as a booster shot.

Antibody drug discovery biotech raises $12m in seed funding

Infinimmune, a biotech pioneering new methods for antibody drug discovery and development, has closed a $12 million seed round: helping it develop its R&D capabilities.